References
- Carvlin M., Renshaw P. F., Dougherty L. et coll. Application of paramagnetic and superparamagnetic contrast agents to probe renal physiology in the rabbit. Society for Magnetic Resonance Imaging, 5th Annual Meeting. San Antonio 1987
- Chiotellis E., Varvarigou A. 99mTc-labelled N-substituted carbamoyl iminodiacetates. Relationship between structure and biodistribution. Int. J. Nucl. Med. Biol 1980; 7: 1
- Firnau G. Why do Tc-99m chelates work for cholescintigraphy?. Europ. J. Nucl. Med 1976; 1: 137
- Fonda U., Pedersen B. 99m-Tc-diethyl-HIDA. A contribution to the study of its structure. Europ. J. Nucl. Med 1978; 3: 87
- Golman K., Klaveness J., Holtz E., Leunbach I., Rye A. S., Almén T. An MRI contrast medium for the liver and bile. Invest. Radiol, (accepted for publication)
- Hemmingsson A., Carlsten J., Ericsson A., Klaveness J., Sperber G. O., Thuomas Å. K. Relaxation enhancement of the dog liver and spleen by biodegradable superparamagnetic particles in proton magnetic resonance imaging. Acta Radiol 1987; 28: 703
- Lauffer R. B., Greif L., Stark D. D., Vicent A. C., Saini S., Van Wedeen J., Brady T. J. Iron-EHPG as an hepatobiliary MR contrast agent. Initial imaging and biodistribution studies. J. Comput. Assist. Tomogr 1985; 9: 421
- Mendonca-Dias M. H., Lauterbur P. E. Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. Magn. Reson. Med 1986; 3: 328
- Renshaw P. F., McLaughlin A. C., Frey T. G., Leigh J. S., Jr. Ferromagnetic contrast agents. A new approach. Magn. Reson. Med 1986; 3: 217
- Wiesslander R., Saini S., Stark D. D., Wittenberg J., Ferrucci J. T. Dual-contrast MR imaging of liver cancer in rats. Amer. J. Roentgenol 1988; 150: 561
- Wolf G. L., Burnett K. R., Goldstein E. J., Joseph P. M. Contrast agents for magnetic resonance imaging. Magnetic resonance annual 1985, H. Y. Kressel. Raven Press, New York 1985; 231